GlassScriptPhysician profile
Richard Sola
NPI 1245228626
$41,469.28
in general payments reported to CMS, 2019-2025
32 companies · $11K in 2025
The $11K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,427 · 2021: $928 · 2022: $4,722 · 2023: $2,496 · 2024: $7,402 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $19K · Food and Beverage: $2,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $18,638.88 |
| Food and Beverage | $2,270.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $22,349.75 | 2022-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $6,208.23 | 2019-2020 | |
| Penumbra, INC. | $4,488.90 | 2019-2023 | Indigo System |
| Cardiovascular Systems INC. | $1,609.67 | 2019-2023 | Diamondback Peripheral |
| Shockwave Medical, INC | $1,560.91 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $916.13 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Zimmer Biomet Holdings, INC. | $805.00 | 2019 | |
| Boston Scientific Corporation | $665.42 | 2019-2025 | Varithena Administration Pack, Ranger, Eluvia |
| Abbott Laboratories | $592.74 | 2019-2021 | |
| Medtronic, INC. | $520.50 | 2021-2025 | Hawkone, In.Pact Admiral |
| Amgen INC. | $307.02 | 2019-2025 | Repatha |
| Endologix LLC | $301.13 | 2019 | |
| Cook Medical LLC | $224.41 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $128.16 | 2019-2023 | Farxiga |
| Depuy Synthes Sales INC. | $118.76 | 2023 | Matrixrib |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $77.00 | 2019 | |
| Pfizer INC. | $75.49 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.30 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $70.28 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $67.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $65.11 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $62.90 | 2019-2022 | |
| Abiomed | $60.54 | 2024 | Impella |
| Amarin Pharma, INC. | $39.51 | 2019-2020 | |
| Novo Nordisk INC | $24.95 | 2025 | Wegovy |
| Terumo Medical Corporation | $16.74 | 2025 | R2p Misago |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.28 | 2020 | |
| Bardy Diagnostics, INC. | $13.50 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.76 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Sola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.